Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,522
Total Claims
$2.4M
Drug Cost
1,181
Beneficiaries
$2,070
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-71%
Opioid rate vs peers
0.7% vs 2.2% avg
+47%
Cost per patient vs peers
$2,070 vs $1,411 avg
+43%
Brand preference vs peers
15.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.7%
Opioid Rate
147
Opioid Claims
$1,649
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,402 claims · $2.0M
Generic: 19,039 claims · $484K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 369 | $493K |
| Empagliflozin | 127 | $158K |
| Rivaroxaban | 124 | $125K |
| Apixaban | 116 | $108K |
| Levothyroxine Sodium | 1,042 | $107K |
| Sitagliptin Phos/Metformin Hcl | 85 | $90K |
| Insulin Glargine,hum.Rec.Anlog | 111 | $81K |
| Sitagliptin Phosphate | 64 | $76K |
| Semaglutide | 61 | $70K |
| Insulin Glargine,hum.Rec.Anlog | 140 | $70K |
| Dulaglutide | 45 | $57K |
| Insulin Lispro | 33 | $32K |
| Empaglifloz/Linaglip/Metformin | 25 | $29K |
| Sitagliptin Phos/Metformin Hcl | 29 | $25K |
| Empagliflozin/Metformin Hcl | 16 | $23K |
Prescribing Profile
Patient Profile
74
Avg Age
68%
Female
2.51
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data